Jidong X. Zhao

Hebei Provincial Key Laboratory Of Tumor Microenvironment And Drug Resistance
Shijiazhuang, 050017, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment.

Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment.

Journal: OncoTargets and therapy
Published: August 29, 2025

The prognostic value of tumor deposits in esophageal squamous cell carcinoma: A propensity score matching study.

The prognostic value of tumor deposits in esophageal squamous cell carcinoma: A propensity score matching study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 08, 2025

A pan-cancer analysis of the oncogenic and immunological roles of THOC3 in human cancer.

A pan-cancer analysis of the oncogenic and immunological roles of THOC3 in human cancer.

Journal: Scientific reports
Published: September 18, 2024

Association between surgery treatment delays and survival outcomes in patients with esophageal cancer in Hebei, China.

Association between surgery treatment delays and survival outcomes in patients with esophageal cancer in Hebei, China.

Journal: Frontiers in oncology
Published: July 12, 2024

Health prevention intervention for chronic tissue fibrosis: Based on the specific expression of CCL19/21 + mast cell.

Health prevention intervention for chronic tissue fibrosis: Based on the specific expression of CCL19/21 + mast cell.

Journal: Preventive medicine
Published: May 04, 2023

Distal-continual colon interposition for esophageal reconstruction after esophagectomy: Two case reports.

Distal-continual colon interposition for esophageal reconstruction after esophagectomy: Two case reports.

Journal: Frontiers in surgery
Published: November 15, 2022

Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma.

Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma.

Journal: Frontiers in bioscience (Landmark edition)
Published: June 04, 2022

Posttreatment Recurrence and Death Patterns in Patients with Advanced Esophageal Cancer.

Posttreatment Recurrence and Death Patterns in Patients with Advanced Esophageal Cancer.

Journal: Disease markers
Published: May 16, 2022

The Survival and Prognosis Characteristics of Primary Esophageal Small-Cell Carcinoma.

The Survival and Prognosis Characteristics of Primary Esophageal Small-Cell Carcinoma.

Journal: Disease markers
Published: May 05, 2022

Folate Receptor 4-Expressing T cell Is Associated with Disease-Free Survival in Patients with Esophageal Squamous Cell Carcinoma.

Folate Receptor 4-Expressing T cell Is Associated with Disease-Free Survival in Patients with Esophageal Squamous Cell Carcinoma.

Journal: Disease markers
Published: April 21, 2022

Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: September 15, 2021

Poor Prognosis of Pulmonary Adenosquamous Carcinoma with NRAS and HRAS Double Mutation.

Poor Prognosis of Pulmonary Adenosquamous Carcinoma with NRAS and HRAS Double Mutation.

Journal: OncoTargets and therapy
Published: December 04, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026